DNA quantification and ploidy patterns in human adrenocortical neoplasms

Area of Science:

• Oncology
• Pathology
• Molecular Biology

Background:

• Adrenocortical tumors require accurate classification for effective treatment.
• Distinguishing benign from malignant adrenal lesions is clinically significant.
• Predicting tumor behavior is crucial for patient management.

Purpose of the Study:

• To evaluate DNA ploidy and cell cycle analysis for differentiating benign and malignant adrenal tumors.
• To assess the predictive value of these parameters for tumor behavior.
• To correlate cytometric findings with clinical classifications of adrenal cortex tumors.

Main Methods:

• Analysis of 32 adrenal tissue samples (normal, adenomas, carcinomas).
• DNA quantification using image analysis of Feulgen-stained sections (Ahrens System) with ACAS3 software.
• Assessment of DNA content (ploidy), 5c-exceeding rate (5cER), and S-phase fraction.

Main Results:

• Diploid DNA content was observed in normal and benign adrenal groups, but not in carcinomas.
• Carcinomas predominantly showed triploid or tetraploid DNA content.
• 100% of carcinomas exhibited a 5cER > 5%, absent in normal and benign cases.
• S-phase fraction exceeded 33% in 83% of carcinomas, compared to 8% in adenomas and 0% in normal adrenals.

Conclusions:

• DNA ploidy and cell cycle parameters are highly effective in distinguishing adrenocortical carcinomas from benign adenomas.
• These quantitative analyses correlate well with the clinical behavior and malignancy of adrenal cortex tumors.
• The study supports the utility of image cytometry in the diagnosis and prognosis of adrenal neoplasms.